Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.  2023, , 3448.

Hassel JC; Zimmer L; Sickmann T; Eigentler TK; Meier F; Mohr P; Pukrop T; Roesch A; Vordermark D; Wendl C; Gutzmer R

doi:10.3390/cancers17233726

← 뒤로

Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. 2023, , 3448.

1/5 보강

Cancers 📖 저널 OA 100% 2021~2026 2025 Vol.17(23)

Hassel JC, Zimmer L, Sickmann T, Eigentler TK, Meier F, Mohr P

📖 무료 전문 🟢 PMC 전문 PMC12691055

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

📝 환자 설명용 한 줄

There was an error regarding the affiliations for Alexander Roesch [...].

이 논문을 인용하기

↓ .bib ↓ .ris

APA Hassel JC, Zimmer L, et al. (2025). Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. 2023, , 3448.. Cancers, 17(23). https://doi.org/10.3390/cancers17233726

MLA Hassel JC, et al.. "Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. 2023, , 3448.." Cancers, vol. 17, no. 23, 2025.

PMID 41375089 ↗

DOI 10.3390/cancers17233726

Abstract

There was an error regarding the affiliations for Alexander Roesch [...].

같은 제1저자의 인용 많은 논문 (1)

IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology 2026

이 논문을 인용하기

Abstract 한글 요약

같은 제1저자의 인용 많은 논문 (1)

Abstract